서울대학교 의과대학 임상약리학교실

Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults

Sae Im Jeong, Yun Kim, Jae Jin Nah, Wan Huh, In-Jin Jang, Jun Gi Hwang, SeungHwan Lee

British journal of clinical pharmacology. 2023,Apr;89(4):1462-1470. doi: 10.1111/bcp.15613. Epub 2022 Dec 8.

Editorial: deja vu all over again - let the P-CAB wars begin. Authors' reply

Inyoung Hwang, SeungHwan Lee

Alimentary pharmacology & therapeutics. 2023,Apr;57(8):914-915. doi: 10.1111/apt.17444.

Pharmacokinetics, safety and tolerability of valbenazine in Korean CYP2D6 normal and intermediate metabolizers

Woo Kyung Chung, Inyoung Hwang, Byungwook Kim, Jihyun Jung, Kyung-Sang Yu, In-Jin Jang, Jaeseong Oh

Clinical and translational science. 2023,Mar;16(3):512-523. doi: 10.1111/cts.13466. Epub 2022 Dec 27.

Effect of Food on the Pharmacokinetics and Pharmacodynamics of a Novel Dual Delayed-Release Formulation of Esomeprazole in Healthy Subjects

Sejung Hwang, Sung Hee Hong, Jina Jung, Jae-Yong Chung, In-Jin Jang, SeungHwan Lee

Clinical pharmacology in drug development. 2023,Mar;16. doi: 10.1002/cpdd.1237. Online ahead of print.

Evaluation of CYP2C19-Mediated Pharmacokinetic Drug Interaction of Tegoprazan, Compared with Vonoprazan or Esomeprazole

Eunsol Yang, Sang Chun Ji, In-Jin Jang, SeungHwan Lee

Clinical pharmacokinetics. 2023,Mar; 10. doi: 10.1007/s40262-023-01228-4. Online ahead of print.

Prediction of gastric pH-mediated drug exposure using physiologically-based pharmacokinetic modeling: A case study of itraconazole

Eunsol Yang, Kyung-Sang Yu, SeungHwan Lee

CPT: pharmacometrics & systems pharmacology. 2023,Mar;26. doi: 10.1002/psp4.12959. Online ahead of print.

Randomised clinical trial: Safety, tolerability, pharmacodynamics and pharmacokinetics of zastaprazan (JP-1366), a novel potassium-competitive acid blocker, in healthy subjects

Inyoung Hwang, Sang Chun Ji, Jaeseong Oh, Hyojin Kim, Hyunju Cha, Jonhn Kim, Chang-Seok Lee, Kyug-Sang Yu, SeungHwan Lee

Alimentary pharmacology & therapeutics. 2023,Feb;2. doi: 10.1111/apt.17406. Online ahead of print.

Development of a Fast Onset Proton Pump Inhibitor: Comparison of Fixed-Dose Combination of Rabeprazole and Sodium Bicarbonate (YPI-011) to the Conventional Enteric-Coated Rabeprazole

Sungyeun Bae, Jihoon Kwon, Mi-Hye Lee, Kyung-Sang Yu, SeungHwan Lee

Drug design, development and therapy. 2023,Feb;15;17:497-506. doi: 10.2147/DDDT.S391716. eCollection 2023.

Effect of hemodialysis on the pharmacokinetics and pharmacodynamics of evogliptin

Byungwook Kim, Dha Woon Im, Heejae Won, Jung Sunwoo, Seung Seok Han, Hajeong Lee, Dong Ki Kim, Kook-Hwan Oh, Kwon Wook Joo 2, Yon Su Kim 2, Joo-Youn Cho, SeungHwan Lee, Jaeseong Oh, In-Jin Jang, Yong Chul Kim

Diabetes, obesity & metabolism. 2023,Feb;28. doi: 10.1111/dom.15034. Online ahead of print.

Pharmacodynamic and Pharmacokinetic Drug Interactions between Fexuprazan, a Novel Potassium-Competitive Inhibitor, and Aspirin, in Healthy Subjects

JungJin Oh, Eunsol Yang, In-Jin Jang, Hyejung Lee, Hokyun Yoo, Jae-Yong Chung, SeungHwan Lee, Jaeseong Oh

Pharmaceutics. 2023,Feb; 7;15(2):549. doi: 10.3390/pharmaceutics15020549.

Effects of food and race on the pharmacokinetics of lazertinib in healthy subjects and patients with EGFR mutation-positive advanced non-small cell lung cancer

Ki Young Huh, Yeji Lim, Deok Yong Yoon, Jun Gi Hwang, Sujin Sim, Jiah Kang, Jangyoung Wang, Mikyung Kim, Seong Bok Jang, S Martin Shreeve, Jaydeep Mehta, Nahor Haddish-Berhane, Jaeseong Oh, SeungHwan Lee, Kyung-Sang Yu

LUNG CANCER 2023,Jan;;175:112-120. doi: 10.1016/j.lungcan.2022.11.021. Epub 2022 Dec 2.

Evaluation of Safety, Tolerability and Pharmacokinetic Characteristics of SA001 and Its Active Metabolite Rebamipide after Single and Multiple Oral Administration

Sungyeun Bae, Ki Young Huh, Jaeseong Oh, Kyung-Sang Yu, Anhye Kim

Pharmaceuticals. 2023,Jan;16;16(1):132. doi: 10.3390/ph16010132.

Comparison of Pharmacodynamics between Tegoprazan and Dexlansoprazole Regarding Nocturnal Acid Breakthrough: A Randomized Crossover Study. Gut Liver.

Sungpil Han, Hee Youn Choi, Yo Han Kim, SeungChan Choi, Seokuee Kim, Ji Yeon Nam, Bongtae Kim, Geun Seog Song, Hyeong-Seok Lim, Kyun-Seop Bae

Gut and liver 2023,Jan;15;17(1):92-99. doi: 10.5009/gnl220050. Epub 2022 Nov 1.

Comparison of Pharmacodynamics between Tegoprazan and Dexlansoprazole Regarding Nocturnal Acid Breakthrough: A Randomized Crossover Study. Gut Liver.

Sungpil Han, Hee Youn Choi, Yo Han Kim, SeungChan Choi, Seokuee Kim, Ji Yeon Nam, Bongtae Kim, Geun Seog Song, Hyeong-Seok Lim, Kyun-Seop Bae

Gut and liver 2023,Jan;15;17(1):92-99. doi: 10.5009/gnl220050. Epub 2022 Nov 1.

Comparison of Pharmacodynamics between Tegoprazan and Dexlansoprazole Regarding Nocturnal Acid Breakthrough: A Randomized Crossover Study. Gut Liver.

Sungpil Han, Hee Youn Choi, Yo Han Kim, SeungChan Choi, Seokuee Kim, Ji Yeon Nam, Bongtae Kim, Geun Seog Song, Hyeong-Seok Lim, Kyun-Seop Bae

Gut and liver 2023,Jan;15;17(1):92-99. doi: 10.5009/gnl220050. Epub 2022 Nov 1.

Reversal of rocuronium-induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis

Sang-Hwan Ji, Ki Young Huh, Jaeseong Oh, Hee-Jeong Jeong, Young-Eun Jang, Eun-Hee Kim, Ji-Hyun Lee, Jin-Tae Kim, Hee-Soo Kim

Clinical and translational science. 2023,Jan;16(1):92-103. doi: 10.1111/cts.13429. Epub 2022 Oct 17.